(ATN) Clarification: Hydrogen Peroxide

DonateNow
Print this article

(ATN) Clarification: Hydrogen Peroxide

AIDS TREATMENT NEWS #134, September 6, 1991
John S. James


Two readers have called AIDS TREATMENT NEWS about our note on hydrogen peroxide ("Warning: Hydrogen Peroxide Might Stimulate HIV Growth," issue #132, August 9, 1991).

* One scientist was concerned that our note might be misunderstood by laboratory personnel, who often use hydrogen peroxide to clean up laboratory spills of fluids containing HIV. Hydrogen peroxide is well- accepted for this use (inactivating the free virus on a surface). Our warning only applied to drinking dilute hydrogen peroxide, or bathing in it, as an HIV treatment. We referred to preliminary findings that hydrogen peroxide, in lower concentrations inside cells, could stimulate HIV growth.

One historical note is that public-health experts considered hydrogen peroxide as an alternative to bleach for cleaning injection-drug needles (when the alternative was that contaminated needles would be re-used with no cleaning at all). Apparently both substances are about equally effective in killing the virus on surfaces. Bleach (aqueous sodium hypochlorite) was chosen because hydrogen peroxide can easily deteriorate if stored improperly, and users would not know that it had lost its potency.

* Another reader was unable to find substantiation for our concern that hydrogen peroxide can act biochemically within infected cells to increase HIV growth. One recently-published article, which we did not have when we went to press, is "Reactive Oxygen Intermediates as Apparently Widely Used Messengers in the Activation of the NF-Kappa-B Transcription Factor and HIV-1," by Ralf Schreck and others, EMBO JOURNAL pages 2247-2258, August 1991.


910906
ATN13405


Copyright © 1991 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .